Source: Eur Respir J, 52 (5) 1800951; 10.1183/13993003.00951-2018



Rating:

Share or cite this content

Citations should be made in the following way:
Suzanne Miller, Clare Coveney, Janice Johnson, Aliki-Eleni Farmaki, Nishant Gupta, Martin D. Tobin, Louise V. Wain, Francis X. McCormack, David J. Boocock, Simon R. Johnson. The vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis. Eur Respir J, 52 (5) 1800951; 10.1183/13993003.00951-2018

Member's Comments

No comment yet.

Related content which might interest you: Vitamin D binding protein: a new biomarker of disease severity in lymphangioleiomyomatosis Source: Eur Respir J, 52 (5) 1801886; 10.1183/13993003.01886-2018 Year: 2018 Vitamin D receptor and vitamin D binding protein polymorphisms are associated with asthma control in children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 Does relationship exist between severity of vitamin D deficiency and development of active TB? Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 Association of vitamin D deficiency with COPD and vitamin D binding proteins Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 The relationship of vitamin D binding protein polymorphisms with blood vitamin D Level in Korean patients with COPD Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19 Source: Eur Respir J, 57 (5) 2004638; 10.1183/13993003.04638-2020 Year: 2021 Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19 Source: Eur Respir J, 57 (5) 2100653; 10.1183/13993003.00653-2021 Year: 2021 Association between Gc genotype and susceptibility to TB is dependent on vitamin D status Source: Eur Respir J 2010; 35: 1106-1112 Year: 2010 The relationship between vitamin D deficiency and the main characteristics of COPD patients Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Vitamin D is suppressed in systemic inflammatory response syndrome Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 Vitamin D predicts disease progression in patients with pulmonary fibrosis and blunts in-vitro fibrotic responses Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 The role of vitamin D in asthmatic disease Source: Breathe 2010; 7: 194-195 Year: 2010 Acute wheeze-specific gene module shows correlation with vitamin D and asthma medication Source: Eur Respir J, 55 (1) 1901330; 10.1183/13993003.01330-2019 Year: 2020 Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001 Prognostic and functional significance of osteoporosis and vitamin D deficiency in interstitial lung diseases Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Does vitamin D deficiency & bone fragility affect pulmonary function in cystic fibrosis? Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Vitamin D receptor polymorphisms and exacerbation frequency in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Vitamin D deficiency and exacerbation frequency in COPD Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 The role of vitamin D in severe asthma Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017